Effects of Basic Body Awareness Therapy Added to Aerobic Exercise in Women With Fibromyalgia
BBAT-FMS
2 other identifiers
interventional
40
0 countries
N/A
Brief Summary
This study aims to investigate the effects of Basic Body Awareness Therapy combined with aerobic exercise on inflammatory biomarkers (interleukin-6 and cortisol), cognitive functions, and depression levels in women diagnosed with fibromyalgia syndrome. Participants will be randomly assigned to an intervention group receiving aerobic exercise plus Basic Body Awareness Therapy or a control group receiving aerobic exercise alone. Clinical, biochemical, cognitive, and psychological assessments will be conducted at baseline and after the intervention period. The findings are expected to contribute to evidence-based non-pharmacological rehabilitation approaches for fibromyalgia management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 22, 2025
CompletedFirst Posted
Study publicly available on registry
October 1, 2026
CompletedStudy Start
First participant enrolled
October 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2027
Study Completion
Last participant's last visit for all outcomes
November 15, 2027
October 1, 2026
September 1, 2026
8 months
December 22, 2025
September 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Interleukin-6 (IL-6)
Changes in serum interleukin-6 (IL-6) concentration will be assessed using standardized laboratory assay methods to evaluate the biological effects of aerobic exercise with or without Basic Body Awareness Therapy in women with fibromyalgia.
Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.
Cortisol
Changes in cortisol concentration will be assessed using standardized laboratory assay methods to evaluate the biological effects of aerobic exercise with or without Basic Body Awareness Therapy in women with fibromyalgia.
Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.
Secondary Outcomes (7)
Cognitive Function Assessed by Trail Making Test
Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.
Depression Level Measured by Depression Anxiety Stress Scale-21 (DASS-21) Depression Subscale
Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.
Pain Intensity Measured by Visual Analog Scale (VAS)
Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.
Pressure Pain Threshold Measured by Pressure Algometer
Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.
Fibromyalgia Disease Severity Assessed by Revised Fibromyalgia Impact Questionnaire (FIQR)
Baseline (before the first exercise session), after the first exercise session (Day 1), and at the end of 12 weeks.
- +2 more secondary outcomes
Study Arms (2)
Aerobic Exercise + Basic Body Awareness Therapy
EXPERIMENTALParticipants in this group will receive a supervised moderate-intensity aerobic exercise program combined with Basic Body Awareness Therapy. The aerobic exercise program will be administered according to standardized protocols, and Basic Body Awareness Therapy will be applied as an adjunct intervention focusing on posture, movement quality, breathing, and body awareness. The intervention will be conducted over the predefined study period under the supervision of a physiotherapist.
Aerobic Exercise Only
EXPERIMENTALParticipants in this group will receive a supervised moderate-intensity aerobic exercise program according to standardized protocols. No additional therapeutic interventions will be applied. The intervention will be conducted over the predefined study period under the supervision of a physiotherapist.
Interventions
Basic Body Awareness Therapy is a physiotherapy-based intervention focusing on movement awareness, posture, balance, breathing, and body perception. The therapy aims to improve movement quality and bodily awareness through guided exercises performed in standing, sitting, and lying positions. Sessions are conducted by a trained physiotherapist according to standardized principles of Basic Body Awareness Therapy.
Moderate-intensity aerobic exercise consists of structured physical activity designed to improve cardiovascular endurance. Exercise intensity is prescribed and monitored according to standardized guidelines. The program is supervised by a physiotherapist and performed regularly throughout the intervention period.
Eligibility Criteria
You may qualify if:
- Female participants aged 30 to 50 years
- Diagnosed with fibromyalgia according to established diagnostic criteria
- Presence of fibromyalgia-related symptoms for at least 3 months
- Physically inactive according to the International Physical Activity Questionnaire (IPAQ) - Short Form (weekly physical activity level \< 600 MET-min/week)
- Willingness to participate voluntarily in the exercise program twice per week for 12 weeks
- Ability to understand study procedures and provide written informed consent
You may not qualify if:
- Presence of any central or peripheral nervous system disease
- Presence of progressive neurological disorders
- Uncontrolled hypertension
- Presence of cardiovascular disease or pathology
- Use of psychotropic medications within the past 1 month
- Presence of any musculoskeletal disorder other than fibromyalgia
- Pregnancy
- Presence of cognitive impairment that may affect cooperation or compliance with study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hacer Önen Tekinlead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- This study is conducted as an open-label trial. Due to the nature of the interventions (aerobic exercise and Basic Body Awareness Therapy), blinding of participants, care providers, and investigators is not feasible. All participants and researchers are aware of group allocation throughout the study period.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
December 22, 2025
First Posted
October 1, 2026
Study Start (Estimated)
October 15, 2026
Primary Completion (Estimated)
June 15, 2027
Study Completion (Estimated)
November 15, 2027
Last Updated
October 1, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared. The study is a single-center, thesis-based academic research project, and data sharing is not planned beyond aggregate results reported in scientific publications, in accordance with ethics committee approval and participant consent.